TABLE 2.
Chronic Inflammation and Fibrosis in TCDD-Treated SiO2–Exposed Mice
Wet weight |
Hydroxyproline |
|||||||
Vehicle + peanut oil | Vehicle + TCDD | Silica + peanut oil | Silica + TCDD | Vehicle + peanut oil | Vehicle + TCDD | Silica + peanut oil | Silica + TCDD | |
Sequential | 126.0 ± 3.7 | 109.7 ± 7.0 | 164.8 ± 12.2* | 171.0 ± 21.0* | 29.38 ± 0.9 | 27.93 ± 0.3 | 37.90 ± 1.5* | 42.03 ± 0.9* |
Concomitant | 102.7 ± 5.0 | 107.9 ± 15.0* | 145.8 ± 3.4* | 140.0 ± 5.5* | 22.09 ± 1.0 | 21.25 ± 0.7 | 29.86 ± 1.2* | 32.65 ± 1.3* |
Notes. Neither sequential nor concomitant exposure to TCDD altered SiO2-induced increases in wet weight and collagen deposition in the lungs of C57Bl/6 mice. In the sequential exposure paradigm, mice were exposed to 25 μl vehicle or 1 mg SiO2 suspended in vehicle once a week for 4 weeks prior to weekly vehicle (200 μl peanut oil) or TCDD (10 mg/kg) oral gavage for the next 8 weeks. In the concomitant exposure paradigm, mice were gavaged weekly with vehicle or TCDD, beginning 1 day prior to being exposed to vehicle or SiO2 suspended in vehicle as described in Supplementary figure 1. Values are means ± SEM.
*p < 0.05 compared with vehicle controls, n = 5–6.